anmelden
SMI Expanded
1.966,36
PKT
-5,92
PKT
-0,30
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.01.22 | Roche Outperform | Bernstein Research | |
| 04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.12.21 | Holcim Buy | Goldman Sachs Group Inc. | |
| 23.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.12.21 | DocMorris Buy | Warburg Research | |
| 21.12.21 | DocMorris Add | Baader Bank | |
| 21.12.21 | ams-OSRAM Buy | Kepler Cheuvreux | |
| 21.12.21 | DocMorris Buy | Jefferies & Company Inc. | |
| 21.12.21 | DocMorris Buy | Warburg Research | |
| 21.12.21 | DocMorris Buy | Baader Bank | |
| 20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.12.21 | Clariant Equal Weight | Barclays Capital | |
| 17.12.21 | Holcim Buy | UBS AG | |
| 17.12.21 | Novartis Sell | Deutsche Bank AG | |
| 17.12.21 | Clariant Neutral | Goldman Sachs Group Inc. | |
| 17.12.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 15.12.21 | Roche Neutral | UBS AG | |
| 15.12.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 15.12.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.12.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 14.12.21 | UBS Outperform | Credit Suisse Group | |
| 14.12.21 | UBS Buy | Jefferies & Company Inc. | |
| 14.12.21 | UBS Outperform | RBC Capital Markets | |
| 13.12.21 | UBS Buy | Kepler Cheuvreux | |
| 13.12.21 | Zurich Insurance Overweight | Barclays Capital | |
| 13.12.21 | Swiss Re Overweight | Barclays Capital | |
| 13.12.21 | Roche Neutral | Credit Suisse Group | |
| 13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.12.21 | Novartis Neutral | Credit Suisse Group | |
| 13.12.21 | Zurich Insurance Overweight | Morgan Stanley | |
| 10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. |
